Karlsson Sundbaum et al. performed 6,288 alanine aminotransferase (ALT) tests during a long-term follow-up of 213 RA patients receiving MTX and found only 7% of ALT tests were over the upper limit of normal (ULN) (14). This evidence concerns the gene GPT and rheumatoid arthritis.